{"id":{"repo_id":"uiuc","oai_identifier":"oai:www.ideals.illinois.edu:2142/84823"},"canonical_url":"https://search.dev.ndltd.org/etd/uiuc/oai:www.ideals.illinois.edu:2142/84823","repository":{"repo_id":"uiuc","name":"University of Illinois - Urbana-Champaign","base_url":"https://www.ideals.illinois.edu/oai-pmh"},"display":{"title":"Biochemical Characterization of CXCR4 Interactions With HIV -1, Natural Ligands and De Novo Designed Inhibitors","abstract":"Chemokines and their receptors are implicated in a wide range of human diseases including Acquired Immune Deficiency Syndrome (AIDS) and HIV-associated dementia (HAD). The entry of human immunodeficiency virus type 1 (HIV-1) into the cell is initiated by the interaction of its surface envelope protein with two cell surface components of the target cell, CD4 and a chemokine coreceptor, usually CXCR4 or CCR5. The natural ligand of CXCR4 is stromal cell-derived factor (SDF)-1alpha. Whereas the overlap between HIV-1 and SDF-1alpha functional sites on the extracellular domains of CXCR4 has been well documented, it is yet to be determined whether there are sites in CXCR4 important for HIV-1 and/or SDF-1alpha functions and, if such sites do exist, whether they are overlapping or distinctive for the separate functions of CXCR4. In this study, we found that the mutations of many CXCR4 transmembrane (TM) and the second extracellular loop (ECL2) residues could selectively decrease HIV-1 mediated cell fusion without impairing the normal SDF-1alpha function, which may suggest a mechanistic basis for the discovery of new selective anti-HIV agents. In conjunction with the mutational analysis of CXCR4, the structure-function relationship of two important chemokines, SDF-1alpha and viral macrophage inflammatory protein (vMIP)-II, was studied. To enable the applications of chemokines as probes of receptor biology and inhibitors of pathological processes, a major problem with the lack of receptor selectivity of natural chemokines must be overcome. Here, we combined total protein synthesis with modular modifications to generate a new class of unnatural chemokines, termed SMM (S&barbelow;ynthetically and M&barbelow;odularly M&barbelow;odified)-chemokines, that were chemically engineered with significantly enhanced selectivity and potency for CXCR4 or CCR5, and improved pharmacological profiles. In addition to being valuable chemical probes of receptor biology to study ligand binding and signaling mechanisms, these novel molecules were shown to be promising leads for the development of anti-HIV and -HAD therapeutics, as they were more potent in blocking HIV-1 entry and infection and less toxic than natural chemokines. The mutational mapping analysis also revealed that SMM-chemokines, particularly those unnatural D-amino acid-containing analogs, share many CXCR4 binding sites with HIV-1 gp120 and yet differ from SDF-1alpha.","abstract_html":"Chemokines and their receptors are implicated in a wide range of human diseases including Acquired Immune Deficiency Syndrome (AIDS) and HIV-associated dementia (HAD). The entry of human immunodeficiency virus type 1 (HIV-1) into the cell is initiated by the interaction of its surface envelope protein with two cell surface components of the target cell, CD4 and a chemokine coreceptor, usually CXCR4 or CCR5. The natural ligand of CXCR4 is stromal cell-derived factor (SDF)-1alpha. Whereas the overlap between HIV-1 and SDF-1alpha functional sites on the extracellular domains of CXCR4 has been well documented, it is yet to be determined whether there are sites in CXCR4 important for HIV-1 and/or SDF-1alpha functions and, if such sites do exist, whether they are overlapping or distinctive for the separate functions of CXCR4. In this study, we found that the mutations of many CXCR4 transmembrane (TM) and the second extracellular loop (ECL2) residues could selectively decrease HIV-1 mediated cell fusion without impairing the normal SDF-1alpha function, which may suggest a mechanistic basis for the discovery of new selective anti-HIV agents. In conjunction with the mutational analysis of CXCR4, the structure-function relationship of two important chemokines, SDF-1alpha and viral macrophage inflammatory protein (vMIP)-II, was studied. To enable the applications of chemokines as probes of receptor biology and inhibitors of pathological processes, a major problem with the lack of receptor selectivity of natural chemokines must be overcome. Here, we combined total protein synthesis with modular modifications to generate a new class of unnatural chemokines, termed SMM (S&barbelow;ynthetically and M&barbelow;odularly M&barbelow;odified)-chemokines, that were chemically engineered with significantly enhanced selectivity and potency for CXCR4 or CCR5, and improved pharmacological profiles. In addition to being valuable chemical probes of receptor biology to study ligand binding and signaling mechanisms, these novel molecules were shown to be promising leads for the development of anti-HIV and -HAD therapeutics, as they were more potent in blocking HIV-1 entry and infection and less toxic than natural chemokines. The mutational mapping analysis also revealed that SMM-chemokines, particularly those unnatural D-amino acid-containing analogs, share many CXCR4 binding sites with HIV-1 gp120 and yet differ from SDF-1alpha.","abstract_has_math":false,"creators":["Choi, Won-Tak"],"institution":"University of Illinois at Urbana-Champaign","degree_name":"Ph.D.","degree_level":"Dissertation","degree_discipline":"Biochemistry","degree_department":null,"school":null,"contributors":["Ziwei Huang"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2015,"date_issued":"2015-09-25T22:28:04Z","date_published":"2015-09-25T22:28:04Z","updated_at":"2026-07-22T22:26:24Z","subjects":["Biology, Physiology"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["(MiAaPQ)AAI3223567"],"render_values":[{"text":"(MiAaPQ)AAI3223567","href":null,"code":true}]}]},"links":{"outbound_url":"http://hdl.handle.net/2142/84823","outbound_label":"Handle","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Ziwei Huang"]},{"key":"dc:creator","label":"Author","values":["Choi, Won-Tak"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2015-09-25T22:28:04Z","10000-01-01","2006"]},{"key":"dc:type","label":"Dc Type","values":["text"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Biochemistry"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Dissertation"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Ph.D."]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["University of Illinois at Urbana-Champaign"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Biology, Physiology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["http://hdl.handle.net/2142/84823","(MiAaPQ)AAI3223567"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Chemokines and their receptors are implicated in a wide range of human diseases including Acquired Immune Deficiency Syndrome (AIDS) and HIV-associated dementia (HAD). The entry of human immunodeficiency virus type 1 (HIV-1) into the cell is initiated by the interaction of its surface envelope protein with two cell surface components of the target cell, CD4 and a chemokine coreceptor, usually CXCR4 or CCR5. The natural ligand of CXCR4 is stromal cell-derived factor (SDF)-1alpha. Whereas the overlap between HIV-1 and SDF-1alpha functional sites on the extracellular domains of CXCR4 has been well documented, it is yet to be determined whether there are sites in CXCR4 important for HIV-1 and/or SDF-1alpha functions and, if such sites do exist, whether they are overlapping or distinctive for the separate functions of CXCR4. In this study, we found that the mutations of many CXCR4 transmembrane (TM) and the second extracellular loop (ECL2) residues could selectively decrease HIV-1 mediated cell fusion without impairing the normal SDF-1alpha function, which may suggest a mechanistic basis for the discovery of new selective anti-HIV agents. In conjunction with the mutational analysis of CXCR4, the structure-function relationship of two important chemokines, SDF-1alpha and viral macrophage inflammatory protein (vMIP)-II, was studied. To enable the applications of chemokines as probes of receptor biology and inhibitors of pathological processes, a major problem with the lack of receptor selectivity of natural chemokines must be overcome. Here, we combined total protein synthesis with modular modifications to generate a new class of unnatural chemokines, termed SMM (S&barbelow;ynthetically and M&barbelow;odularly M&barbelow;odified)-chemokines, that were chemically engineered with significantly enhanced selectivity and potency for CXCR4 or CCR5, and improved pharmacological profiles. In addition to being valuable chemical probes of receptor biology to study ligand binding and signaling mechanisms, these novel molecules were shown to be promising leads for the development of anti-HIV and -HAD therapeutics, as they were more potent in blocking HIV-1 entry and infection and less toxic than natural chemokines. The mutational mapping analysis also revealed that SMM-chemokines, particularly those unnatural D-amino acid-containing analogs, share many CXCR4 binding sites with HIV-1 gp120 and yet differ from SDF-1alpha.","Made available in DSpace on 2015-09-25T22:28:04Z (GMT). No. of bitstreams: 2 license.txt: 4848 bytes, checksum: 96035ab3f5e1c23cc7138a224ce498bd (MD5) 3223567.pdf: 4934511 bytes, checksum: bdb458dcf532042fa01262b04329566c (MD5) Previous issue date: 2006","Embargo set by: Seth Robbins for item 86104 Lift date: Forever Reason: Restricted to the U of I community idenfinitely during batch ingest of legacy ETDs","Restricted to the U of I community idenfinitely during batch ingest of legacy ETDs","U of I Only","180 p.","Thesis (Ph.D.)--University of Illinois at Urbana-Champaign, 2006."]},{"key":"dc:title","label":"Title","values":["Biochemical Characterization of CXCR4 Interactions With HIV -1, Natural Ligands and De Novo Designed Inhibitors"]}]}],"canonical_facts":{"dc:contributor":["Ziwei Huang"],"dc:creator":["Choi, Won-Tak"],"dc:date":["2015-09-25T22:28:04Z","10000-01-01","2006"],"dc:description":["Chemokines and their receptors are implicated in a wide range of human diseases including Acquired Immune Deficiency Syndrome (AIDS) and HIV-associated dementia (HAD). The entry of human immunodeficiency virus type 1 (HIV-1) into the cell is initiated by the interaction of its surface envelope protein with two cell surface components of the target cell, CD4 and a chemokine coreceptor, usually CXCR4 or CCR5. The natural ligand of CXCR4 is stromal cell-derived factor (SDF)-1alpha. Whereas the overlap between HIV-1 and SDF-1alpha functional sites on the extracellular domains of CXCR4 has been well documented, it is yet to be determined whether there are sites in CXCR4 important for HIV-1 and/or SDF-1alpha functions and, if such sites do exist, whether they are overlapping or distinctive for the separate functions of CXCR4. In this study, we found that the mutations of many CXCR4 transmembrane (TM) and the second extracellular loop (ECL2) residues could selectively decrease HIV-1 mediated cell fusion without impairing the normal SDF-1alpha function, which may suggest a mechanistic basis for the discovery of new selective anti-HIV agents. In conjunction with the mutational analysis of CXCR4, the structure-function relationship of two important chemokines, SDF-1alpha and viral macrophage inflammatory protein (vMIP)-II, was studied. To enable the applications of chemokines as probes of receptor biology and inhibitors of pathological processes, a major problem with the lack of receptor selectivity of natural chemokines must be overcome. Here, we combined total protein synthesis with modular modifications to generate a new class of unnatural chemokines, termed SMM (S&barbelow;ynthetically and M&barbelow;odularly M&barbelow;odified)-chemokines, that were chemically engineered with significantly enhanced selectivity and potency for CXCR4 or CCR5, and improved pharmacological profiles. In addition to being valuable chemical probes of receptor biology to study ligand binding and signaling mechanisms, these novel molecules were shown to be promising leads for the development of anti-HIV and -HAD therapeutics, as they were more potent in blocking HIV-1 entry and infection and less toxic than natural chemokines. The mutational mapping analysis also revealed that SMM-chemokines, particularly those unnatural D-amino acid-containing analogs, share many CXCR4 binding sites with HIV-1 gp120 and yet differ from SDF-1alpha.","Made available in DSpace on 2015-09-25T22:28:04Z (GMT). No. of bitstreams: 2 license.txt: 4848 bytes, checksum: 96035ab3f5e1c23cc7138a224ce498bd (MD5) 3223567.pdf: 4934511 bytes, checksum: bdb458dcf532042fa01262b04329566c (MD5) Previous issue date: 2006","Embargo set by: Seth Robbins for item 86104 Lift date: Forever Reason: Restricted to the U of I community idenfinitely during batch ingest of legacy ETDs","Restricted to the U of I community idenfinitely during batch ingest of legacy ETDs","U of I Only","180 p.","Thesis (Ph.D.)--University of Illinois at Urbana-Champaign, 2006."],"dc:identifier":["http://hdl.handle.net/2142/84823","(MiAaPQ)AAI3223567"],"dc:language":["eng"],"dc:subject":["Biology, Physiology"],"dc:title":["Biochemical Characterization of CXCR4 Interactions With HIV -1, Natural Ligands and De Novo Designed Inhibitors"],"dc:type":["text"],"thesis:degree_discipline":["Biochemistry"],"thesis:degree_level":["Dissertation"],"thesis:degree_name":["Ph.D."],"thesis:institution_name":["University of Illinois at Urbana-Champaign"]},"updated_at":"2026-07-22T22:26:24Z"}